Skip to main content
SpringerLink
Log in

A new inclusion complex of amlodipine besylate and soluble β-cyclodextrin polymer: preparation, characterization and dissolution profile

  • Original Article
  • Published:
Journal of Inclusion Phenomena and Macrocyclic Chemistry Aims and scope Submit manuscript

Abstract

Amlodipine besylate (AML) has become the most popular blood pressure medication for hypertensive pets. It belongs to the class I (high solubility and high permeability) according to BCS and is marketed in Europe only as white tablets equivalent to 2.5, 5.0 and 10.0 mg of amlodipine for oral administration. Unfortunately, oral AML dosage for cats and dogs is in the range 0.1–0.2 and 0.625–0.125 mg/kg/die respectively. Moreover, AML shows a slight solubility in water according to Ph. Eur. 7°. According to these considerations, the aim of this work was the complexation between soluble β-cyclodextrin polymer (CD) and AML using the solubilization/freeze-dried method to obtain powders easily dosable and soluble in water for the treatment of hypertension in pets. The complex in solution was evaluated by phase solubility studies that indicated the optimal 2:1 drug/CD ratio to form a stable complex. UV–Vis absorption and circular dichroism showed the formation of a complex with a weak bond such as confirmed by differential scanning calorimetry, infrared spectroscopy and fluorescence microscopy. In vitro dissolution/release tests were performed in water to investigate the influence of formulative parameters on drug dissolution/release properties. The inclusion of AML in CD increased its wettability, dissolution rate and solubility in water. This method could be a suitable approach for the administration of an extemporaneous solution of the antihypertensive drug to guarantee a correct dose to pets increasing the compliance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Brooks W.C.: Veterinary Partner. http://www.veterinarypartner.com/Content.plx?P=A&C=31&A=1215&S=0 (2009). Accessed 1 Nov 2011

  2. Clavijo, G.A., de Clavijo, I.V., Weart, C.W.: Amlodipine: a new calcium antagonist. Am. J. Hosp. Pharm. 51(1), 59–68 (1994)

    CAS  Google Scholar 

  3. Murdoch, D., Heel, R.C.: Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 41(3), 478–505 (1991)

    Article  CAS  Google Scholar 

  4. Cooke, K.L., Snyder, P.S.: Calcium channel blockers in veterinary medicine. J. Vet. Intern. Med. 12(3), 123–131 (1998)

    Article  CAS  Google Scholar 

  5. Fasani, E., Albini, A., Gemme, S.: Mechanism of the photochemical degradation of amlodipine. Int. J. Pharm. 352(1–2), 197–201 (2008)

    Article  CAS  Google Scholar 

  6. Brewster, M.E., Loftsson, T.: Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 59, 645–666 (2007)

    Article  CAS  Google Scholar 

  7. Nikolić, V., Nikolić, L., Stanković, M., Cakić, M., Stanojević, L., Ilić, D.: Inclusion complexes of amlodipine besylate and cyclodextrins. Cent. Eur. J. Chem. 8(4), 834–841 (2010)

    Article  Google Scholar 

  8. Mielcarek, J., Czernielewska, A., Czarczyńska, B.: Inclusion complexes of felodipine and amlodipine with methyl-β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 54(1–2), 17–21 (2006)

    Article  CAS  Google Scholar 

  9. Ling, W., Xuehua, J., Weijuan, X., Chenrui, L.: Complexation of tanshinone IIA with 2-hydroxypropyl-b-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats. Int. J. Pharm. 341, 58–67 (2007)

    Article  Google Scholar 

  10. Puglisi, G., Santagati, N.A., Ventura, C.A., Pignatello, R., Panico, A.M., Spampinato, S.: Enhancement of 4-biphenylacetic acid bioavailability in rats by its β-cyclodextrin complex after oral administration. J. Pharm. Pharmacol. 43, 430–432 (1991)

    Article  CAS  Google Scholar 

  11. Puglisi, G., Ventura, C.A., Spadaro, A., Campana, G., Spampinato, S.: Differential effects of modified β-cyclodextrins on pharmacological activity and bioavailability of 4-biphenylacetic acid in rats after oral administration. J. Pharm. Pharmacol. 47, 120–123 (1995)

    Article  CAS  Google Scholar 

  12. Ventura, C.A., Fresta, M., Giovinazzo, C., Puglisi,` G.: Solid state characterization and in solution studies of idebenone-β-cyclodextrin inclusion complex. Acta Tecnol. Legis Medicam. VI, 56–66, N.1 (1995)

  13. Ventura, C.A., Fresta, M., Vandelli, M.A., Cavallaro, G., Zappalà, M.T., Puglisi, G.: Preparation and physico-chemical study of inclusion complexes between idebenone and β-cyclodextrin. J. Incl. Phenom. Mol. Recognit. Chem. 24, 193–210 (1996)

    Article  Google Scholar 

  14. Ventura, C.A., Giannone, I., Paolino, D., Pistarà, V., Corsaro, A., Puglisi, G.: Preparation of celecoxib-dimethyl-β-cyclodextrin inclusion complex: characterization and in vitro permeation study. Eur. J. Med. Chem. 40, 624–631 (2005)

    Article  CAS  Google Scholar 

  15. Amididouche, D., Darrouzet, H., Duchene, D., Poelman, M.C.: Inclusion of retinoic acid. J. Pharm. Sci. Technol. 2(3), 171–183 (2010)

    Google Scholar 

  16. Duchene, D., Vaution, C., Glomot, F.: Amelioration de la dissolution et de la biodisponibilitè des principles actifs par inclusion dans ls cyclodextrines. STP Pharma. 1, 323–332 (1985)

    Google Scholar 

  17. Somagoni, J.M., Dharani, S., Panakanti, P.K., Koorelli, S., Manda, S., Madhusudan, R.Y.: Stereospecific dissolution of inclusion complexes of amlodipine base and its besylate enantiomers with hydroxypropyl-β-cyclodextrin. Lat. Am. J. Pharm. 30(7), 1309–1316 (2011)

    CAS  Google Scholar 

  18. Somagoni, J., Reddy, S., Katakam, V.K., Koorelli, S., Manda, S., et al.: Preparation of inclusion complexes of amlodipine base and its besylate and maleate salts with hydroxy propyl β-cyclodextrin—a study on stereospecific dissolution. Pharm. Anal. Acta 2, 123 (2011). doi:10.4172/2153-2435.1000123v

    CAS  Google Scholar 

  19. Vélaz, I., Isasi, J.R., Sánchez, M., Uzqueda, M., Ponchel, G.: Structural characteristics of some soluble and insoluble β-cyclodextrin polymers. J. Incl. Phenom. Macrocycl. Chem. 57(1–4), 65–68 (2007)

    Article  Google Scholar 

  20. Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins 1 drug solubilization and stabilization. J. Pharm. Sci. 85(10), 1017–1025 (1996)

    Article  CAS  Google Scholar 

  21. Nianbing, L., Jianping, D., Hongqing, C., Guonan, C.: Determination of the binding constant for the inclusion complex between procaine hydrochloride and b-cyclodextrin by capillary electrophoresis. Talanta 59, 493–499 (2003)

    Article  Google Scholar 

  22. Benesi, H.A., Hildebrand, J.H.: A spectrophotometric investigation of the interaction of iodine with aromatic hydrocarbons. J. Am. Chem. Soc. 71, 2703–2707 (1949)

    Article  CAS  Google Scholar 

  23. Guo, Q.X., Liu, H.Y., Ruan, X.Q., Zheng, X.Q., Shi, Y.Y., Liu, Y.C.: Experimental and theoretical studies on the inclusion complexation of β-cyclodextrin with phenothiazine derivatives. J. Incl. Phenom. Macrocycl. Chem. 35, 487–496 (1999)

    Article  CAS  Google Scholar 

  24. Göktürk, S., Çalıskan, E., Talman, R.Y., Var Marmara, U.: A study on solubilization of poorly soluble drugs by cyclodextrins and micelles: complexation and binding characteristics of sulfamethoxazole and trimethoprim. http://www.tswj.com/aip/718791.pdf. Accessed 12 March 2012

  25. Higuchi, T., Connors, K.A.: Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4, 117–212 (1965)

    CAS  Google Scholar 

  26. Chadna, R., Kashid, N., Saini, A.: Account of analytical employed techniques for the determination of thermodynamics of inclusion complexation of drugs with cyclodextrins. J. Sci. Ind. Res. 63, 211–229 (2004)

    Google Scholar 

  27. Spulber, M., Pinteala, M., Harabagiu, V., Simionescu, B.C., Fifere, A.: Spectroscopic characterization of α-cyclodextrin–sulconazole inclusion complexes. Determination of binding constants by Rose–Drago approximation. Rom. Soc. Med. Mycol. Mycotoxicol. 2(2), 189–192 (2008)

    Google Scholar 

  28. Loftsson, T., Hreinsdottir, D., Masson, M.: Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302, 18–28 (2005)

    Article  CAS  Google Scholar 

  29. Fernandes, C., Viera, M.T., Veiga, F.: Physicochemical chraracterization and in vitro dissolution behavior of nicardipine–cyclodextrins inclusion compounds. Eur. J. Pharm. Sci. 15, 79–88 (2002)

    Article  CAS  Google Scholar 

  30. Ammar, H.O., Salama, H.A., Ghorab, M., Mahmoud, A.A.: Inclusion complexation of glimepiride in dimethyl-β-cyclodextrin. Asian J. Pharm. Sci. 2(2), 44–55 (2007)

    CAS  Google Scholar 

  31. Cupka, P., Bella, J., Martvon, A.: Synthesis and spectral properties of substituted 1,4 dihydropiridines and 1,4,5,6,7,8-hexahydroquinolines. Collect. Czechoslov. Chem. Commun. 52, 742–775 (1987)

    Article  CAS  Google Scholar 

  32. Jadhav, G.S., Vavia, P.R., Nandedkar, D.T.: Danazol-β-cyclodextrin binary system: a potential application in emergency contraception by the oral route. AAPS PharmSciTech. 8(2), Article 35 (2007). doi:10.1208/pt0802035

  33. Xiang, T.X., Andersoon, B.D.: Inclusion complexes of purine nucleosides with cyclodextrins: II. Investigation of inclusion complex geometry and cavity microenvironment. Int. J. Pharm. 59(1), 45–55 (1990)

    Article  CAS  Google Scholar 

  34. Marini, A., Berbenni, V., Bruni, G., Mustarelli, P., Giordano, F., Villa, M.: Thermoanalytical and spectroscopic characterization of betacyclodextrin/ketoprofen inclusion complexes. J. Incl. Phenom. Mol. Recognit. Chem. 22, 221–234 (1995)

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Angelo Basile for his useful contribution.

Author information

Authors and Affiliations

  1. Dipartimento di Scienze Farmaceutiche e Biomediche, Università degli Studi di Salerno, Via Ponte Don Melillo, 84084, Fisciano, SA, Italy

    M. R. Lauro & R. P. Aquino

  2. Dipartimento di Scienze del Farmaco, Università degli Studi di Catania, Viale A. Doria, 6, 95125, Catania, CT, Italy

    C. Carbone, R. Auditore, T. Musumeci, N. A. Santagati & G. Puglisi

Authors
  1. M. R. Lauro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Carbone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Auditore
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Musumeci
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. A. Santagati
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. P. Aquino
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. Puglisi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. R. Lauro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lauro, M.R., Carbone, C., Auditore, R. et al. A new inclusion complex of amlodipine besylate and soluble β-cyclodextrin polymer: preparation, characterization and dissolution profile. J Incl Phenom Macrocycl Chem 76, 19–28 (2013). https://doi.org/10.1007/s10847-012-0168-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10847-012-0168-y

Keywords

Search

Navigation